Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma	Large B-Cell Lymphoma (LBCL)	Not yet recruiting	Phase 1 / Phase 2	2025-12-08		NCT07269639

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Seoul National University Hospital	277

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Seoul National University Hospital	Seoul	South Korea	393

Clinical trials